Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Practice Support

Subcategories:EMRsFacilityInsuranceQuality Assurance/ImprovementTechnology

Fraud and Abuse: What’s the Difference?

  |  

Each year, fraud and abuse cost the Medicare and Medicaid programs billions of dollars. What is the difference between fraud and abuse? The Centers for Medicare & Medicaid Services define fraud and abuse as two different offenses…

National HMO Class-Action Case Settled

  |  

The latest development in the healthcare class-action settlement will affect approximately 900,000 physicians (and some major state medical societies) who may be eligible to receive compensation from the settlement – as long as they file a claim. The case has been called “historic” by those representing both physicians and insurance companies.

Innovative Educational Programs for Rheumatology APNs and PAs

Karen L. Kerr, MSN, NP, CPNP, APRN-BC  |  

Arthritis and other rheumatic diseases affect more than 46 million adults and 300,000 children in the United States. With the aging of the U.S. population, the number of adults with rheumatic disease is expected to increase to 67 million by 2030.1 While the demand for rheumatology services is increasing, the supply of practicing rheumatologists is diminishing. The ACR Rheumatology Workforce Study (published earlier this year) predicts that there will be little or no increase in the number of practicing rheumatologists, resulting in a critical shortage of rheumatologists by 2020.

Consultation or Referral? That Is the Question

  |  

One of the most troublesome coding decisions is determining whether a visit is a consultation or a referral. To avoid the hassle of incorrect coding, one must first understand the difference between a consultation and a referral.

Enhanced Opportunities at the 2007 Meeting

  |  

The AMPC is using more translational components as a way of increasing the basic scientist’s interaction with clinicians, he explains. In keeping with this, the meeting will offer sessions on osteoclasts, implications for the development and treatment of osteoarthritis, T-cell subsets, and a year in review – all of which will be of interest to both the clinician and the basic researcher.

Let’s Talk Tech

Neal S. Birnbaum, MD  |  

As microchips permeate medicine, our new council will spearhead electronic initiatives